Last reviewed · How we verify
Comirnaty Omicron XBB1.5
At a glance
| Generic name | Comirnaty Omicron XBB1.5 |
|---|---|
| Sponsor | Hipra Scientific, S.L.U |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Safety and Immunogenicity of a Booster Vaccination With an Adapted Vaccine (PHASE2, PHASE3)
- Bringing Optimised COVID-19 Vaccine Schedules To ImmunoCompromised Populations (BOOST-IC): an Adaptive Randomised Controlled Clinical Trial (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |